Literature DB >> 28882892

Structural features of human inositol phosphate multikinase rationalize its inositol phosphate kinase and phosphoinositide 3-kinase activities.

Huanchen Wang1, Stephen B Shears2.   

Abstract

Human inositol phosphate multikinase (HsIPMK) critically contributes to intracellular signaling through its inositol-1,4,5-trisphosphate (Ins(1,4,5)P3) 3-kinase and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) 3-kinase activities. This catalytic profile is not conserved; orthologs from Arabidopsis thaliana and Saccharomyces cerevisiae are predominantly Ins(1,4,5)P3 6-kinases, and the plant enzyme cannot phosphorylate PtdIns(4,5)P2 Therefore, crystallographic analysis of the yeast and plant enzymes, without bound inositol phosphates, do not structurally rationalize HsIPMK activities. Here, we present 1.6-Å resolution crystal structures of HsIPMK in complex with either Ins(1,4,5)P3 or PtdIns(4,5)P2 The Ins(1,4,5)P3 headgroup of PtdIns(4,5)P2 binds in precisely the same orientation as free Ins(1,4,5)P3 itself, indicative of evolutionary optimization of 3-kinase activities against both substrates. We report on nucleotide binding between the separate N- and C-lobes of HsIPMK. The N-lobe exhibits a remarkable degree of conservation with protein kinase A (root mean square deviation = 1.8 Å), indicating common ancestry. We also describe structural features unique to HsIPMK. First, we observed a constrained, horseshoe-shaped substrate pocket, formed from an α-helix, a 310 helix, and a recently evolved tri-proline loop. We further found HsIPMK activities rely on a preponderance of Gln residues, in contrast to the larger Lys and Arg residues in yeast and plant orthologs. These conclusions are supported by analyzing 14 single-site HsIPMK mutants, some of which differentially affect 3-kinase and 6-kinase activities. Overall, we structurally rationalize phosphorylation of Ins(1,4,5)P3 and PtdIns(4,5)P2 by HsIPMK.

Entities:  

Keywords:  X-ray crystallography; enzyme catalysis; inositol phosphate; kinase; phosphatidylinositol kinase (PI kinase); phosphatidylinositol signaling; protein kinase A (PKA); signaling; substrate specificity

Mesh:

Substances:

Year:  2017        PMID: 28882892      PMCID: PMC5672042          DOI: 10.1074/jbc.M117.801845

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  High-throughput structural biology in drug discovery: protein kinases.

Authors:  T J Stout; P G Foster; D J Matthews
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.

Authors:  Seyun Kim; Sangwon F Kim; David Maag; Micah J Maxwell; Adam C Resnick; Krishna R Juluri; Anutosh Chakraborty; Michael A Koldobskiy; Seung Hun Cha; Roxanne Barrow; Adele M Snowman; Solomon H Snyder
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

Review 3.  Inositol phosphate metabolomics: merging genetic perturbation with modernized radiolabeling methods.

Authors:  Jill Stevenson-Paulik; Shean-Tai Chiou; Josh P Frederick; June dela Cruz; Andrew M Seeds; James C Otto; John D York
Journal:  Methods       Date:  2006-06       Impact factor: 3.608

Review 4.  PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis.

Authors:  Giulia Ramazzotti; Irene Faenza; Roberta Fiume; Anna Maria Billi; Lucia Manzoli; Sara Mongiorgi; Stefano Ratti; James A McCubrey; Pann-Ghill Suh; Lucio Cocco; Matilde Y Follo
Journal:  Adv Biol Regul       Date:  2016-10-18

5.  A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.

Authors:  Yoshitatsu Sei; Xilin Zhao; Joanne Forbes; Silke Szymczak; Qing Li; Apurva Trivedi; Mark Voellinger; Grishma Joy; Jianying Feng; Millie Whatley; MaryPat Sussex Jones; Ursula L Harper; Stephen J Marx; Aradhana M Venkatesan; Settara C Chandrasekharappa; Mark Raffeld; Martha M Quezado; Adeline Louie; Clara C Chen; Ramona M Lim; Richa Agarwala; Alejandro A Schäffer; Marybeth S Hughes; Joan E Bailey-Wilson; Stephen A Wank
Journal:  Gastroenterology       Date:  2015-04-09       Impact factor: 22.682

6.  Direct modification and activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMK.

Authors:  Raymond D Blind; Miyuki Suzawa; Holly A Ingraham
Journal:  Sci Signal       Date:  2012-06-19       Impact factor: 8.192

7.  The absence of expression of the three isoenzymes of the inositol 1,4,5-trisphosphate 3-kinase does not prevent the formation of inositol pentakisphosphate and hexakisphosphate in mouse embryonic fibroblasts.

Authors:  Alexandre Leyman; Valérie Pouillon; Alionka Bostan; Stéphane Schurmans; Christophe Erneux; Xavier Pesesse
Journal:  Cell Signal       Date:  2007-02-03       Impact factor: 4.315

8.  Inositol 1,4,5,6-tetrakisphosphate is phosphorylated in rat liver by a 3-kinase that is distinct from inositol 1,4,5-trisphosphate 3-kinase.

Authors:  A Craxton; C Erneux; S B Shears
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

9.  Inositol pentakisphosphate mediates Wnt/beta-catenin signaling.

Authors:  Yuan Gao; Hsien-yu Wang
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

10.  Human inositol polyphosphate multikinase regulates transcript-selective nuclear mRNA export to preserve genome integrity.

Authors:  Vihandha O Wickramasinghe; Jane M Savill; Sreenivas Chavali; Asta B Jonsdottir; Eeson Rajendra; Tamara Grüner; Ronald A Laskey; M Madan Babu; Ashok R Venkitaraman
Journal:  Mol Cell       Date:  2013-09-26       Impact factor: 17.970

View more
  12 in total

1.  Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.

Authors:  Chunfang Gu; Michael A Stashko; Ana C Puhl-Rubio; Molee Chakraborty; Anutosh Chakraborty; Stephen V Frye; Kenneth H Pearce; Xiaodong Wang; Stephen B Shears; Huanchen Wang
Journal:  J Med Chem       Date:  2019-01-25       Impact factor: 7.446

Review 2.  The Inositol Phosphate System-A Coordinator of Metabolic Adaptability.

Authors:  Becky Tu-Sekine; Sangwon F Kim
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

3.  Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions.

Authors:  Yubai Zhou; Sandip Mukherjee; Daowei Huang; Molee Chakraborty; Chunfang Gu; Guangning Zong; Michael A Stashko; Kenneth H Pearce; Stephen B Shears; Anutosh Chakraborty; Huanchen Wang; Xiaodong Wang
Journal:  J Med Chem       Date:  2022-04-25       Impact factor: 8.039

Review 4.  Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease.

Authors:  Jamal M Bryant; Raymond D Blind
Journal:  J Lipid Res       Date:  2018-09-10       Impact factor: 5.922

Review 5.  Advances in chemical proteomic evaluation of lipid kinases-DAG kinases as a case study.

Authors:  Timothy B Ware; Ku-Lung Hsu
Journal:  Curr Opin Chem Biol       Date:  2021-07-23       Impact factor: 8.822

Review 6.  Inositol phosphate kinases: Expanding the biological significance of the universal core of the protein kinase fold.

Authors:  Stephen B Shears; Huanchen Wang
Journal:  Adv Biol Regul       Date:  2018-10-27

7.  Blue light excited retinal intercepts cellular signaling.

Authors:  Kasun Ratnayake; John L Payton; O Harshana Lakmal; Ajith Karunarathne
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

8.  Crystallographic and kinetic analyses of human IPMK reveal disordered domains modulate ATP binding and kinase activity.

Authors:  Corey D Seacrist; Raymond D Blind
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

9.  Inositol phosphate kinases in the eukaryote landscape.

Authors:  Debabrata Laha; Paloma Portela-Torres; Yann Desfougères; Adolfo Saiardi
Journal:  Adv Biol Regul       Date:  2020-12-29

10.  Inositol Pyrophosphate Synthesis by Diphosphoinositol Pentakisphosphate Kinase-1 is Regulated by Phosphatidylinositol(4,5)bisphosphate.

Authors:  Vasudha S Nair; Chunfang Gu; Agnes K Janoshazi; Henning J Jessen; Huanchen Wang; Stephen B Shears
Journal:  Biosci Rep       Date:  2018-02-19       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.